Practical enantiospecific synthesis of RPR 111905: A novel non-peptide substance P antagonist

被引：10

作者：

Mutti, S

Daubie, C

Malpart, J

Radisson, X

机构：

[1] Rhone-Poulenc Rorer - Ctr. de R., Chemical Process - 13, Quai Jules Guesde, 94403 Vitry sur Seine

来源：

TETRAHEDRON LETTERS | 1996年 / 37卷 / 48期

关键词：

D O I：

10.1016/S0040-4039(96)02017-5

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The synthesis of enantiomerically pure RPR 111905 was achieved in twelve steps with an overall yield of 6.9%. The synthetic strategy was based on a Diels-Alder reaction to generate the bicyclic framework and the asymmetry was introduced by resolution. Copyright (C) 1996 Elsevier Science Ltd

引用

页码：8743 / 8746

页数：4

共 50 条

[31] Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice
Li, Yong-Jie
Li, Xiao-Hong
Wang, Liang-Fen
Kuang, Xi
Hang, Zhi-Xiong
Deng, Yong
Du, Jun-Rong
EXPERIMENTAL EYE RESEARCH, 2014, 129 : 119 - 126
[32] Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist
DeVita, RJ
Hollings, DD
Goulet, MT
Wyvratt, MJ
Fisher, MH
Lo, JL
Yang, YT
Cheng, K
Smith, RG
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) : 2615 - 2620
[33] Design and synthesis of a non-peptide PAR1 thrombin receptor antagonist, using cyclohexane as template
Androustou, Maria-Eleni
Agelis, George
Magoulas, George
Saifeddine, Mahmound
Hollenberg, Morley
Matsoukas, John
JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 144 - 144
[34] RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks
Diener, HC
CEPHALALGIA, 2003, 23 (03) : 183 - 185
[35] Synthesis, binding studies, and in vivo biological evaluation of novel non-peptide antihypertensive analogues
Mavromoustakos, T.
Moutevelis-Minakakis, P.
Kokotos, C. G.
Kontogianni, P.
Politi, A.
Zoumpoulakis, P.
Findlay, J.
Cox, A.
Balmforth, A.
Zoga, A.
Iliodromitis, E.
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (13) : 4353 - 4360
[36] DESIGN AND SYNTHESIS OF NOVEL POTENT, NON-PEPTIDE AND ORALLY ACTIVE RENIN INHIBITORS.
Grutter, M.
Maibaum, J.
Rasetti, V.
Rueger, H.
Goschke, R.
Mah, R.
Cohen, N. C.
Rahuel, J.
Cumin, F.
Wood, J.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C583 - C583
[37] NOVEL NON-PEPTIDE PHARMACOLOGIC THERAPY FOR NOCTURIA IN MEN
Imnadze, Mariam
Weiss, Jeffrey
Yea, Christopher
Marks, Brian
McElwaine-Johnn, Hilary
Nathadwarawala, Mahendra
JOURNAL OF UROLOGY, 2010, 183 (04): : E590 - E590
[38] Discovery and development of novel non-peptide neurokinin antagonists
Bernstein, Peter R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[39] Synthesis and pharmacological profile of non-peptide vasopressin antagonists
Galanski, ME
Erker, T
Studenik, CR
Kamyar, M
Rawnduzi, P
Pabstova, M
Lemmens-Gruber, R
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (05) : 421 - 431
[40] Design, synthesis, and evaluation of novel non-peptide peptidomimetic inhibitors of aspartic proteases.
Bursavich, MG
Rich, DH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U687 - U688

← 1 2 3 4 5 →